⌘K

Login Start Free

Home/Filings/4/0001725160-25-000047

4//SEC Filing

Bruns Ingmar 4

Accession 0001725160-25-000047

CIK 0001725160other

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 5:00 PM ET

Size

4.8 KB

Accession

0001725160-25-000047

Insider Transaction Report

Form 4

Period: 2025-02-06

Zentalis Pharmaceuticals, Inc.ZNTL

Chief Medical Officer

Transactions

Purchase
Common Stock
2025-02-06$2.28/sh+20,000$45,656→ 36,629 total

Documents

1 file

4
wk-form4_1739397624.xmlPrimary
FORM 4

Issuer

Zentalis Pharmaceuticals, Inc.

CIK 0001725160

Entity typeother

Related Parties

1

filerCIK 0001838041

Filing Metadata

Form type: 4
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 5:00 PM ET
Size: 4.8 KB

View on SEC.gov